Innealta Capital’s Nu Skin NUS Stock Holding History

Innealta Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7	Closed	-$74	–	1167
2024 Q2	$74	Buy	+7	New	+$89	﹤0.01%	1716

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Innealta Capital's NUS Position: Q3 2024 in Review

Innealta Capital sold out of Nu Skin (NUS) in Q3 2024, closing a stake of 7 shares — an estimated $74 sold.

Innealta Capital first reported a position in NUS in Q2 2024 and held it in 1 quarter. The position peaked at $74 in Q2 2024. 203 funds tracked by Wall St. Rank hold NUS as of Q3 2024.

Innealta Capital reported no remaining Nu Skin position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 7 Nu Skin shares in Q3 2024, an estimated $74.
Innealta Capital first reported a position in Nu Skin in Q2 2024 and held it in 1 quarter.
Innealta Capital's Nu Skin position peaked at $74 in Q2 2024.
203 funds tracked by Wall St. Rank held Nu Skin as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.